Over-the-Counter Sales of Statins and Other Drugs for Asymptomatic Conditions  

Oleh:

Tinetti, Mary E.

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: The New England Journal of Medicine (keterangan: ada di Proquest) vol. 358 no. 25 (Jun. 2008), page 2728.

Ketersediaan

Perpustakaan FK Nomor Panggil: N08.K.2008.03 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

Merck recently submitted its third application to the Food and Drug Administration (FDA) to allow it to sell its cholesterol-lowering drug lovastatin in 20-mg tablets over the counter.1,2 Targeted consumers are men over the age of 45 years and women over the age of 55 years who have levels of low-density lipoprotein (LDL) cholesterol of 130 to 170 mg per deciliter and an intermediate 10-year risk of a cardiovascular event (5 to 20%) but no previous event.1 Merck's arguments for the switch from prescription-only to over-the-counter sales focused on the "treatment gap" — at-risk persons who are not receiving therapy . . .

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali